Tonix Pharmaceuticals Holding Balance Sheet (2010-2026) | TNXP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation (Quarter)	0.37M	0.40M	0.46M	0.56M	0.82M	1.65M	2.55M	3.47M	4.39M	5.36M	6.33M	3.09M	3.60M	4.10M	4.59M	5.07M	5.53M	6.02M	6.58M	7.20M
Assets
Current Assets
Cash & Equivalents (Quarter)	182.97M	178.90M	140.44M	145.48M	139.98M	120.47M	71.97M	25.62M	6.91M	25.85M	7.05M	0.02M	28.23M	99.68M	131.72M	101.50M	97.60M	207.64M	155.10M	176.23M
Receivables - Net (Quarter)									1.56M	4.59M		3.34M	1.63M	3.68M	3.31M	2.32M	3.48M	6.27M	8.82M	11.80M
Receivables - Other (Quarter)						8.04M		1.56M		4.59M	2.50M		2.13M	0.95M	1.29M	1.90M	1.67M	3.48M	3.39M	3.25M
Receivables (Quarter)									1.56M	9.18M		3.34M	3.76M	4.64M	4.60M	4.22M	5.15M	9.76M	12.21M	15.05M
Raw Materials (Quarter)										3.61M			3.35M	3.07M	2.65M	2.35M	2.48M	2.51M
Work In Process (Quarter)										2.54M			1.95M	0.21M	0.66M	1.27M	1.49M	1.37M
Finished Goods (Quarter)										7.49M			2.63M	5.12M	4.82M	2.37M	1.76M	2.14M
Inventory (Quarter)								13.70M	13.34M	0.51M	12.35M	9.46M	0.34M	8.41M	8.14M	5.99M	5.73M	1.00M	3.65M	4.68M
Prepaid Assets (Quarter)	12.11M	1.48M	12.55M	14.77M	11.16M	1.27M	11.75M	12.01M	9.54M	9.18M	10.70M	8.34M	2.12M	1.39M	1.07M	0.69M	8.81M	1.65M	9.23M	10.72M
Current Assets (Quarter)	195.08M	189.05M	152.99M	191.75M	151.14M	130.78M	83.73M	51.33M	31.34M	47.77M	30.10M	25.29M	50.54M	119.00M	149.57M	143.53M	208.07M	228.88M	207.17M	203.43M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	18.23M	50.56M	69.59M	83.10M	90.31M	93.81M	93.99M	95.72M	94.87M	94.03M	93.06M	43.25M	42.75M	42.25M	41.77M	42.34M	42.57M	44.46M	44.89M	44.76M
Goodwill (Quarter)								0.96M	0.96M	0.96M	0.96M
Intangibles (Quarter)	0.12M	0.12M				0.12M		10.10M	9.98M	9.62M	9.38M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M
Goodwill & Intangibles (Quarter)	0.12M	0.12M				0.12M		11.06M	10.95M	10.59M	10.35M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M
Other Non-Current Assets (Quarter)	0.24M	0.38M	0.38M	0.38M	0.36M	0.26M	0.39M	0.29M	1.05M	1.13M	0.96M	0.96M	0.95M	0.95M	0.90M	0.93M	1.30M	0.01M	0.01M	4.55M
Non-Current Assets (Quarter)	19.69M	51.85M	70.73M	84.42M	91.51M	94.91M	95.36M	108.41M	107.94M	106.69M	105.25M	45.02M	44.45M	43.89M	43.30M	43.82M	44.37M	48.30M	50.74M	50.66M
Assets (Quarter)	214.77M	240.90M	223.72M	276.17M	242.65M	225.69M	179.09M	159.74M	139.28M	154.46M	135.34M	70.31M	94.99M	162.89M	192.87M	187.36M	252.44M	277.17M	257.91M	254.09M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	7.96M	13.28M	9.40M	9.57M	4.56M	8.07M	8.02M	7.67M	7.80M	3.78M	6.65M	10.41M	3.94M	4.55M	4.19M	7.78M	8.54M	8.11M	9.65M	9.05M
Notes Payables (Quarter)
Payables (Quarter)	7.96M	13.28M	9.40M	9.57M	4.56M	8.07M	8.02M	7.67M	7.80M	3.78M	6.65M	10.41M	3.94M	4.55M	4.19M	7.78M	8.54M	8.11M	9.65M	9.05M
Accumulated Expenses (Quarter)	3.48M	7.95M	5.56M	5.83M	8.28M	9.68M	4.62M	10.33M	9.50M	12.48M	10.73M	0.03M	8.15M	10.67M	7.72M	11.08M	12.33M	22.60M	19.84M	21.48M
Short term Debt (Quarter)										2.35M	2.82M	2.82M	2.82M	2.82M
Current Leases (Quarter)	0.58M	0.49M	0.40M	0.51M	0.50M	0.43M	0.44M	0.44M	0.43M	0.27M	0.28M	0.28M	0.28M	0.27M	0.23M	0.20M	0.16M	0.12M	0.16M	0.25M
Current Deferred Revenue (Quarter)						3.27M				2.98M				1.82M	1.93M	3.01M	2.67M	3.42M	4.23M	3.82M
Total Current Liabilities (Quarter)	12.03M	21.72M	15.35M	15.91M	13.34M	18.18M	13.07M	18.44M	17.73M	18.88M	20.48M	22.04M	15.18M	18.31M	12.15M	19.06M	21.03M	30.84M	29.65M	30.79M
Non-Current Liabilities
Non-Current Debt (Quarter)										6.56M	6.16M	5.67M	5.17M	4.67M
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)				26.25M
Operating Leases (Quarter)	0.47M	0.47M	0.80M	0.33M	0.39M	0.33M	0.53M	0.90M	0.90M	0.63M	0.56M	0.49M	0.70M	0.36M	0.56M	0.30M	0.42M	1.18M	1.29M	1.27M
Other Non-Current Liabilities (Quarter)										8.26M
Total Non-Current Liabilities (Quarter)										40.67M
Total Liabilities (Quarter)	12.56M	22.18M	15.76M	16.38M	13.72M	18.51M	13.66M	19.27M	18.45M	48.93M	27.20M	28.20M	20.78M	23.33M	12.47M	19.36M	21.30M	32.02M	30.77M	31.81M
Shareholder's Equity
Total Debt (Quarter)										8.91M	8.98M	8.49M	7.99M	7.49M
Common Equity (Quarter)	202.22M	218.72M	207.96M	228.28M	228.92M	207.18M	165.43M	140.46M	120.83M	105.53M	108.14M	42.10M	74.21M	139.56M	180.40M	168.00M	231.14M	245.15M	227.14M	222.28M
Liabilities and Shareholders Equity (Quarter)	214.77M	240.90M	223.72M	276.17M	242.65M	225.69M	179.09M	159.74M	139.28M	154.46M	135.34M	70.31M	94.99M	162.89M	192.87M	187.36M	252.44M	277.17M	257.91M	254.09M
Retained Earnings (Quarter)	-0.08M	-0.09M	-0.12M	-409.38M	-438.36M	-0.17M	-516.99M	-0.21M	-573.34M	-600.66M	-615.60M	-0.24M	-0.25M	-0.26M	-0.27M	-0.27M	-807.80M	-854.72M	-0.28M	-935.46M
Treasury Shares (Quarter)				2.50M

Research Tools

Datasets

Plans

Developers

Tonix Pharmaceuticals Holding Balance Sheet (2010-2026) | TNXP

Research Tools

Datasets

Plans

Developers

Tonix Pharmaceuticals Holding Balance Sheet (2010-2026) | TNXP

Create an account

Sign In

Reset Password